These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 21322764)
1. Therapeutic potential of vaccines for Alzheimer's disease. Shah S; Federoff HJ Immunotherapy; 2011 Feb; 3(2):287-98. PubMed ID: 21322764 [TBL] [Abstract][Full Text] [Related]
2. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps]. Kuzuhara S Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463 [TBL] [Abstract][Full Text] [Related]
4. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis. Boche D; Denham N; Holmes C; Nicoll JA Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020 [TBL] [Abstract][Full Text] [Related]
5. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease. Okura Y; Matsumoto Y Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892 [TBL] [Abstract][Full Text] [Related]